BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 7688397)

  • 1. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop.
    Shirai M; Kozlowski S; Margulies DH; Berzofsky JA
    J Immunol; 1997 Apr; 158(7):3181-8. PubMed ID: 9120272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160.
    Shirai M; Kurokohchi K; Pendleton CD; Arichi T; Boyd LF; Takahashi H; Margulies DH; Berzofsky JA
    J Immunol; 1996 Nov; 157(10):4399-411. PubMed ID: 8906815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys.
    Chen ZW; Shen L; Regan JD; Kou Z; Ghim SH; Letvin NL
    J Immunol; 1996 Feb; 156(4):1469-75. PubMed ID: 8568249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
    J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
    Kuhröber A; Schirmbeck R; Reimann J
    Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
    J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of 2,4,6-trinitrophenyl (TNP)-specific, H-2b-restricted cytotoxic T lymphocyte precursors in transgenic mice expressing a T cell receptor beta chain gene from an H-2b-restricted, TNP-specific cytolytic T cell clone.
    Iglesias A; Hansen-Hagge T; Von Bonin A; Weltzien HU
    Eur J Immunol; 1992 Feb; 22(2):335-41. PubMed ID: 1311259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
    Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
    Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C; Stohlmann SA; McMillan M
    Eur J Immunol; 1993 Nov; 23(11):2777-81. PubMed ID: 7693478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant T cell receptor gene elements in TNP-specific cytotoxic T cells.
    Kempkes B; Palmer E; Martin S; von Bonin A; Eichmann K; Ortmann B; Weltzien HU
    J Immunol; 1991 Oct; 147(8):2467-73. PubMed ID: 1840614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.
    Aebischer T; Oehen S; Hengartner H
    Eur J Immunol; 1990 Mar; 20(3):523-31. PubMed ID: 2138558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H; Wakabayashi A; Shimizu M; Kaneko H; Norose Y; Nakagawa Y; Wang J; Kumagai Y; Margulies DH; Takahashi H
    Biochem Biophys Res Commun; 2004 Apr; 316(2):356-63. PubMed ID: 15020225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.
    Brändle D; Bürki K; Wallace VA; Rohrer UH; Mak TW; Malissen B; Hengartner H; Pircher H
    Eur J Immunol; 1991 Sep; 21(9):2195-202. PubMed ID: 1716213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.